期刊文献+

间日疟原虫云南分离株传播阻断疫苗候选抗原Pvs28基因多态性分析 被引量:2

Genetic polymorphism analysis of the candidate antigen Pvs 28 for the transmission-blocking vaccine of vivax malaria parasites isolated in Yunnan province
下载PDF
导出
摘要 目的分析我国疟疾混合流行区云南分离株间日疟原虫(P.v)传播阻断疫苗候选抗原Pvs28基因特点。方法收集云南省血样17份;提取疟原虫基因组DNA;PCR扩增Pvs28基因;基因测序;DnaSPversion4.0软件进行基因多态性分析。结果成功扩增Pvs28全长基因17个序列。与标准株Sal-I比较,检测出7个错义突变,7个基因型和7种氨基酸型。云南P.v分离株核苷酸多态性π值为0.0044。若不考虑重复片段拷贝数的差异,云南P.v分离株和湖北P.v分离株Pvs28蛋白主导氨基酸型完全一致,即V14-L52-L98-E105-L116-S140-I223。与泰国P.v分离株比较,我国主导基因型突变位点完全包含在泰国P.v分离株突变位点中。结论以Sal-IPvs28为基础建立的传播阻断疫苗能够克服云南P.v分离株Pvs28抗原多样性而发挥传播阻断作用,提示间日疟原虫传播阻断疫苗在我国具有良好的应用前景。 The genetic polymorphism of the candidate antigen Pvs 28 for the transmission-blocking vaccine of vivax malaria from Yunnan isolates was analyzed. Seventeen blood samples were collected in the epidemic area of malaria in Yunnan province, and the genomic DNA of malaria parasites was extracted from the collected samples. The Pvs 28 gene was amplified by PCR, and the PCR products were directly sequenced. The genetic polymorphism was analyzed by DnaSP version 4.0 software. In the present study, the full length of Pvs 28 gene with 17 segments of sequences was successfully amplified. Compared with Sal-I sequence, 7 non-synonymous mutations sites, 7 varieties of haplotype and 7 amino acid substitutions were detected. The nueleotide diversity showed that the n value was 0. 0044. The predominant amino acid type was V^14-L^52-L^98-E^105-L^115-S^14-I^122 Regardless of the differences in repeat region of Pvs 28, the predominant amino acid type of Yunnan isolates and Hubei isolates was the same. Compared with the sequences from Thailand isolates, the mutation sites of main haplotyes were included in those of Thailand isolates, It suggests that the vivax transmission-blocking vaccine based on Pvs 28 could overcome the limited genetic mutation and would promise a good prospect for a wide use in China,
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2006年第4期360-362,293,共4页 Chinese Journal of Zoonoses
基金 国家自然科学基金资助项目(No.30371347)
关键词 间日疟原虫 传播阻断疫苗候选抗原 PVS 28 基因多态性 Plasmodium vivax good prospect for a wide use in China, TBV antigen Pvs 28 genetic polymorphism
  • 相关文献

参考文献16

  • 1Robert W Snow, Carlos A Guerra, Abodisalan M Noor, et al. The global distribution of clinical episodes of Plasmodium falci-parum malaria[J]. Nature, 2005, 434(10):214-217. 被引量:1
  • 2Tongren JE, Zavala F, Roos DS, et al. Malaria vaccines: if at first you don't succeed[J]. Trends Parasitol, 2004, 20(12):604-610. 被引量:1
  • 3Arevalo-Herrera M, Herrera S. Plasmodium vivax malaria vaccine development[J]. Mol Immunol, 2001, 38(6) 5443-455. 被引量:1
  • 4Feng X, Carlton JM, Joy DA, et al. Single-nucleotide polymor-phisms and genome diversity in Plasmodium vivax[J]. Proe Natl Acad Sci U S A, 2003, 83100(14):8502-8507. 被引量:1
  • 5Tsuboi T, Kaslow DC, Gozar M, et al. Sequence polymorphism in two novel Plasmodium vlvaz ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmisslon-blocklng vaccine eandidates[J]. Mol Med, 1998, 4(12) :772-782. 被引量:1
  • 6Tsuboi T, Kaneko O, Cao YM, et al. Plasmodium vivax : A rapid genotyping method for the malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28[J]. Parasitol Int, 2004, 53 (3):211-216. 被引量:1
  • 7Tsuboi T, Tachibana M, Kaneko O, et al. Transmission-blocking vaccine of vivax malaria [J]. Parasitol Int, 2003, 52 (1) :1-11. 被引量:1
  • 8阎建忠,徐卫民,刘英杰,郑丽,曹雅明.间日疟原虫中国湖北分离株传播阻断疫苗候选抗原Pvs28的基因多态性分析[J].寄生虫与医学昆虫学报,2003,10(4):193-197. 被引量:2
  • 9Sattabongkot J, Tsuboi T, Hisaeda H, et al. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates[J]. Am J Trop Med Hyg, 2003, 69(5): 536-541. 被引量:1
  • 10Tangri S, Ishioka GY, Huang X, et al. Structural features of peptide analogs of human histoeompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wildtype peptide[J]. J Exp Med, 2001, 194(6):833-846. 被引量:1

二级参考文献28

  • 1[1]Hisaeda,H,A.W.Stowers,T.Tsuboi et al.2000 Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.Infect.Immune,68:6618~6623. 被引量:1
  • 2[2]Tomas,A.M.,G.Margos,G.Dimopoulos et al.2001 P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions.The EMBO Journal,20:3975~3983. 被引量:1
  • 3[3]Tsuboi,T.,Y.M.Cao,Y.Hitsumoto et al.1997 Two distinct target antigens of transmission-blocking immunity on zygotes and ookinetes of Plasmodium yoelii and Plasmodium berghei.Infect.Immune,65:2260~2264. 被引量:1
  • 4[4]Tsuboi,T.,D.C.Kaslow,M.M.Gozar et al.1998 Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins,Pvs25 and Pvs28,that are malaria transmission-blocking vaccine candidates.Mol.Med,4:772~782. 被引量:1
  • 5[5]Tsuboi,T.,M.Tachibana,O.Kaneko et al.2003 Transmission-blocking vaccine of vivax malaria.Parasitol.int,52:1~11. 被引量:1
  • 6[6]WHO.1997.World Malaria Situation in 1994 Weekly Epidemiological Record. 被引量:1
  • 7Shi YP, Alpers MP, Povoa MM, et al. Single amino acid variationin the ookinete vaccine antigen from field isolates of Plasrnodiurn falciparurn [J]. Mol Biochem Parasitol, 1992,50:179-180. 被引量:1
  • 8WHO. Malaria transmission-blocking vaccine: An ideal public good.WHO document(TDR/RBM/MAL/VAC/2000.1 ) available from WHO,Geneva, and on website http://www. who. Int/tdr, 2000. 被引量:1
  • 9Hisaeda H, Stowers AW, Tsuboi T, et al. Antibodies to malariavaccine candidates Pvs25 and Pvs28 completdy block the ability of Plasrnodiurn vivax to infect mosquitoes[J]. Infect Immun, 2000,68: 6618-6623. 被引量:1
  • 10Tomas AM, Margos G, Dimopoulos G, et al. P25 and P28 proteinsof the malaria ookinete surface have multiple and partially redundant functions[J]. The EMBO Journal, 2001,20:3975-3983. 被引量:1

共引文献8

同被引文献59

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部